Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does HYDROCHLOROTHIAZIDE Cause Fall? 1,323 Reports in FDA Database

Lower Your Cholesterol — The Natural Way

The Oxidized Cholesterol Strategy: a science-backed plan for heart health.

See the Strategy

According to the FDA Adverse Event Reporting System (FAERS), 1,323 reports of Fall have been filed in association with HYDROCHLOROTHIAZIDE (Irbesartan and Hydrochlorothiazide). This represents 6.3% of all adverse event reports for HYDROCHLOROTHIAZIDE.

1,323
Reports of Fall with HYDROCHLOROTHIAZIDE
6.3%
of all HYDROCHLOROTHIAZIDE reports
242
Deaths
896
Hospitalizations

How Dangerous Is Fall From HYDROCHLOROTHIAZIDE?

Of the 1,323 reports, 242 (18.3%) resulted in death, 896 (67.7%) required hospitalization, and 84 (6.3%) were considered life-threatening.

Is Fall Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for HYDROCHLOROTHIAZIDE. However, 1,323 reports have been filed with the FAERS database.

What Other Side Effects Does HYDROCHLOROTHIAZIDE Cause?

Hyponatraemia (2,138) Drug ineffective (1,889) Acute kidney injury (1,838) Nausea (1,536) Dyspnoea (1,521) Dizziness (1,469) Headache (1,419) Hypotension (1,347) Malaise (1,312) Fatigue (1,299)

What Other Drugs Cause Fall?

ADALIMUMAB (11,399) CARBIDOPA\LEVODOPA (7,132) LENALIDOMIDE (6,229) ETANERCEPT (5,839) DALFAMPRIDINE (5,554) APIXABAN (5,063) METHOTREXATE (4,250) DIMETHYL (4,208) TOFACITINIB (4,064) PREGABALIN (4,047)

Which HYDROCHLOROTHIAZIDE Alternatives Have Lower Fall Risk?

HYDROCHLOROTHIAZIDE vs HYDROCHLOROTHIAZIDE\IRBESARTAN HYDROCHLOROTHIAZIDE vs HYDROCHLOROTHIAZIDE\LISINOPRIL HYDROCHLOROTHIAZIDE vs HYDROCHLOROTHIAZIDE\LOSARTAN HYDROCHLOROTHIAZIDE vs HYDROCHLOROTHIAZIDE\METOPROLOL HYDROCHLOROTHIAZIDE vs HYDROCHLOROTHIAZIDE\NEBIVOLOL

Related Pages

HYDROCHLOROTHIAZIDE Full Profile All Fall Reports All Drugs Causing Fall HYDROCHLOROTHIAZIDE Demographics